Biotechnology Industry Market Index
The Biotechnology Industry in the Health Care Sector includes companies primarily engaged in the research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering (including companies specializing in protein-based therapeutics to treat human diseases).
The Biotechnology industry index is a market composite index that includes 8 stocks from public trading companies and ADRs with the largest market capitalizations in the Biotechnology industry.
The list of stocks in the Biotechnology industry includes Amgen Inc, Gilead Sciences Inc, AbbVie Inc, Regeneron Pharmaceuticals Inc, Biogen Inc, Incyte Corp, Vertex Pharmaceuticals Inc and Moderna Inc..
9/20/2024 Health Care Sector Biotechnology Industry
$348,184
Change: -0.50%
Open: $348,400
High: $350,293
Low: $345,360
| Amgen Inc (AMGN) |
+0.43%
|
| Gilead Sciences Inc (GILD) |
+0.05%
|
| AbbVie Inc (ABBV) |
-0.08%
|
| Regeneron Pharmaceuticals Inc (REGN) |
-0.45%
|
| Biotechnology Industry |
-0.50%
|
| Biogen Inc (BIIB) |
-1.03%
|
| Incyte Corp (INCY) |
-1.62%
|
| Vertex Pharmaceuticals Inc (VRTX) |
-2.72%
|
| Moderna Inc. (MRNA) |
-3.43%
|
Index Value: $348,184 -0.50%
Volume: 17.56B Average Volume (3 month): 7.89B
Market Capitalization: $287.13T
EBITDA: $26.70T
PEG Ratio (5 year Expected): 6.57
Dividend Yield: 2.20%
Dividend Rate: $6,777
Dividend Yield (Forward): 2.30%
Dividend Rate (Forward): $7,097
Shares Outstanding: 1.91T
Book Value: $42,386
Short Ratio: 2.61
Price Target (1 year): $322,548
Volume: 17.56B Average Volume (3 month): 7.89B
Market Capitalization: $287.13T
EBITDA: $26.70T
PEG Ratio (5 year Expected): 6.57
Dividend Yield: 2.20%
Dividend Rate: $6,777
Dividend Yield (Forward): 2.30%
Dividend Rate (Forward): $7,097
Shares Outstanding: 1.91T
Book Value: $42,386
Short Ratio: 2.61
Price Target (1 year): $322,548
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| AMGN | Amgen Inc | 337.38 | +0.43% | 3.99M | 1.96 | 19.31% |
| GILD | Gilead Sciences Inc | 83.94 | +0.05% | 24.67M | 3.64 | 11.13% |
| ABBV | AbbVie Inc | 193.47 | -0.08% | 4.28M | 0.83 | 36.41% |
| REGN | Regeneron Pharmaceuticals Inc | 1,145.03 | -0.45% | 892,848 | 1.94 | 13.23% |
| Biotechnology Industry | 348,183.95 | -0.50% | 17.56B | 2.23 | 12.99% | |
| BIIB | Biogen Inc | 199.36 | -1.03% | 3.81M | 3.86 | 3.09% |
| INCY | Incyte Corp | 65.74 | -1.62% | 6.80M | 2.97 | 1.35% |
| VRTX | Vertex Pharmaceuticals Inc | 464.92 | -2.72% | 2.18M | 1.92 | 12.78% |
| MRNA | Moderna Inc. | 65.69 | -3.43% | 11.44M | 2.59 | 2.69% |
| Symbol | Security | Market Cap | Div Yield | PEG Ratio |
| AMGN | Amgen Inc | 176.862B | 2.67% | 3.01 |
| GILD | Gilead Sciences Inc | 93.536B | 4.07% | 4.05 |
| ABBV | AbbVie Inc | 347.139B | 3.13% | 2.88 |
| REGN | Regeneron Pharmaceuticals Inc | 130.666B | 2.53 | |
| Biotechnology Industry | $287.13T | 2.20% | 6.57 | |
| BIIB | Biogen Inc | 30.033B | 3.54 | |
| INCY | Incyte Corp | 12.355B | 1.32 | |
| VRTX | Vertex Pharmaceuticals Inc | 125.466B | 123.52 | |
| MRNA | Moderna Inc. | 33.308B | 0.23 | |
Back to Market Summary